Medication Assisted Treatment (MAT) in Los Angeles

Profound Treatment, located in the Woodland Hills area of Los Angeles, offers medication-assisted treatment (MAT) to assist individuals through the withdrawal and recovery process. MAT reduces cravings and mitigates withdrawal symptoms, lowering the chance of relapse. 

What is Medication-Assisted Treatment (MAT)?

Medication-assisted treatment (MAT) is a structured and comprehensive approach to addiction treatment and recovery. MAT programs integrate the use of medications that have received approval from the U.S. Food and Drug Administration (FDA) with counseling and behavioral therapy. These programs are specifically designed to address the complex needs of those battling addiction.

Key Components of a MAT Program:

• FDA-Approved Medications: Medications used in MAT programs have undergone rigorous testing and are recognized by the FDA for their effectiveness in treating addiction. 
• Counseling: A core aspect of MAT, counseling helps individuals gain insights into the psychological aspects of addiction, develop coping strategies, and receive support from peers and professionals.
• Behavioral Therapy: This type of therapy equips individuals with practical tools to manage cravings, triggers, and the challenges of maintaining sobriety.

FDA-Approved Medications for MAT

Medication-assisted treatment relies on a number of FDA-approved medications that target the physical aspects of opiate addiction. These medications are often integral to the success of the overall treatment plan. The three medications approved by the FDA to treat opioid dependence include: 

1. Methadone:

Methadone is a long-acting opioid agonist that helps reduce cravings and withdrawal symptoms associated with opioids like heroin. It binds to the same receptors in the brain that opioids target, providing a stable and controlled effect. Methadone is typically administered under medical supervision in specialized clinics to ensure safety and effective treatment.

2. Buprenorphine:

Buprenorphine, commonly known as Suboxone® or Subutex®, is a partial opioid agonist that activates the same receptors as opioids but to a lesser extent. This medication helps reduce cravings and withdrawal symptoms while having a lower risk of misuse compared to full agonists. Buprenorphine is often prescribed in office-based settings, making it more accessible for individuals struggling with opioid use disorder (OUD).

3. Naltrexone:

Naltrexone, commonly known as Vivitrol®, is an opioid antagonist that works by blocking the effects of opioids in the brain. It helps prevent relapse by making it less appealing to use opioids. Naltrexone can be administered in the form of an extended-release injection or taken as a daily oral medication. This medication is particularly useful for individuals who have successfully completed detoxification and wish to maintain sobriety.

The choice between these medications may vary based on individual needs and medical assessments. Each individual’s unique circumstances should be considered to ensure appropriate and effective treatment. 

How is MAT Used During the Detox Process?

For opiate dependence, the detox phase is formidable, as it is accompanied by intense withdrawal symptoms that can be physically and emotionally challenging. MAT can significantly ease this transition, providing a safer and more comfortable path to sobriety.

During the detox process, the administration of medications such as methadone, buprenorphine, or naltrexone can help stabilize brain function, reduce cravings, and mitigate the severity of withdrawal symptoms. By alleviating discomfort and distress during the initial process of healing, MAT helps make the detox process less intimidating and allows individuals to focus on their recovery without the overwhelming burden of intense withdrawal.

If you or a loved one is looking for support with opiate dependence, you’re not alone. Contact Profound Treatment today to learn more about our detox programs. 

Is MAT Safe for Fentanyl Withdrawal?

Many individuals dealing with opioid addiction, particularly synthetic opioids like fentanyl, express concerns about precipitated withdrawal. This uncomfortable experience occurs when MAT medications are introduced before opioids have fully left the body. It can result in abrupt and severe withdrawal symptoms, intensifying discomfort. 

To prevent this, experienced medical professionals take great care in assessing a patient’s opioid use history and the timing of their last dose before initiating MAT. This cautious approach ensures that MAT medications are introduced safely, minimizing the risk of precipitated withdrawal. Overall, MAT is considered both safe and effective for fentanyl withdrawal when overseen by experienced medical professionals. It eases withdrawal symptoms, reduces cravings, and enhances the early stages of recovery, offering a path toward a healthier, drug-free future.